Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Meadville › NPI 1942276423
Hospital

Meadville Medical Center

Meadville Medical Center was paid $9.55M by Medicaid between Jan 2018 and Dec 2024, across 319 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

33Billing provider infoMEADVILLE MEDICAL CENTER
MEADVILLE, PA 16335
33aNPI1942276423assigned 02/24/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.55M
24GClaims359,667
24DCodes billed319
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#34 of 154
Median peer was paid$2.82M
This provider vs. median3.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SUNTAY, RENATO controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018266$12K
20191,097$5K
202033,257$579K
2021160,888$4.02M
202263,030$2.00M
202358,657$1.66M
2024incomplete42,472$1.27M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 16,414 15,955 $1.04M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.1% 8,669 8,344 $770K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.7% 9,555 9,202 $740K
G0378 Hospital observation service, per hour 6.6% 2,392 1,672 $629K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 5.3% 13,815 4,190 $510K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.7% 14,243 13,775 $453K
0202U Oncology (prostate), multianalyte, gene expression profiling 4.5% 1,724 1,686 $428K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3.2% 1,081 1,066 $306K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2.8% 9,377 9,215 $270K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.8% 1,678 1,619 $266K
X0592 2.3% 7,844 7,068 $216K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 8,959 8,540 $208K
307 more codes
90837 Psychotherapy session, about an hour 2.1% 1,437 $205K
X0616 2.1% 1,129 $200K
80053 Comprehensive metabolic panel 2.1% 24,567 $196K
99285 Emergency room visit (most serious) 1.7% 1,749 $161K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.6% 1,533 $153K
99213 Doctor's office visit, returning patient (routine) 1.5% 3,609 $147K
X0621 1.3% 660 $127K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.2% 5,823 $115K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 27,438 $111K
70450 Computed tomography, head or brain; without contrast material <1% 1,700 $93K
80050 General health panel <1% 1,831 $84K
96375 Therapeutic injection; each additional sequential IV push <1% 4,361 $71K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,614 $65K
64615 <1% 746 $61K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,481 $58K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 771 $57K
0002A <1% 1,216 $49K
71045 Radiologic examination, chest; single view <1% 6,754 $44K
84484 <1% 5,726 $44K
0001A <1% 1,198 $42K
87486 <1% 1,083 $40K
77067 Screening mammography, bilateral, including computer-aided detection <1% 503 $39K
83874 <1% 3,601 $38K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,140 $37K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 925 $34K
81001 <1% 12,637 $32K
80061 Lipid panel <1% 2,486 $31K
71275 Computed tomographic angiography, chest, with contrast material <1% 173 $30K
95811 <1% 82 $30K
62323 <1% 500 $29K
83880 <1% 1,130 $28K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 868 $27K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 784 $26K
82553 <1% 3,597 $26K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 859 $26K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 193 $25K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 458 $24K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,315 $23K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 75 $22K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,165 $22K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 156 $22K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 362 $21K
76830 Ultrasound, transvaginal <1% 484 $21K
84443 Thyroid stimulating hormone (TSH) <1% 1,366 $20K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 97 $20K
83690 <1% 4,810 $20K
87428 <1% 593 $19K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 720 $19K
87040 <1% 1,239 $19K
72141 <1% 94 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 336 $19K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 702 $16K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 682 $16K
97161 <1% 468 $16K
92557 <1% 596 $15K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 227 $15K
93971 <1% 270 $15K
84702 <1% 897 $15K
92567 <1% 1,330 $15K
70551 Magnetic resonance imaging, brain; without contrast material <1% 84 $14K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 363 $14K
73110 <1% 527 $14K
87070 <1% 1,976 $13K
97597 <1% 779 $13K
83735 <1% 2,923 $13K
29848 <1% 26 $13K
71250 <1% 248 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 1,886 $12K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 55 $11K
99214 Doctor's office visit, returning patient (more involved) <1% 197 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 328 $10K
85610 <1% 3,811 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 503 $10K
73630 <1% 921 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 199 $10K
73564 <1% 566 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 431 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 990 $9K
84145 <1% 676 $9K
84703 <1% 975 $9K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 246 $9K
73610 <1% 575 $9K
71046 Radiologic examination, chest; 2 views <1% 754 $9K
83605 <1% 1,282 $8K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 43 $8K
72100 <1% 537 $8K
73030 <1% 640 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,178 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 161 $7K
80081 <1% 92 $7K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 183 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 1,013 $7K
86803 <1% 404 $7K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 362 $7K
87186 <1% 1,018 $7K
84146 <1% 294 $7K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 139 $6K
82728 <1% 682 $6K
99203 Doctor's office visit, new patient (routine) <1% 128 $6K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 14 $6K
76642 <1% 156 $6K
0003A <1% 144 $6K
73130 <1% 555 $6K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 43 $6K
84439 <1% 830 $6K
87150 <1% 132 $6K
93017 <1% 221 $5K
94729 <1% 228 $5K
85730 <1% 1,052 $5K
86618 <1% 230 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 32 $5K
90853 Group psychotherapy (other than of a multiple-family group) <1% 521 $5K
96367 <1% 268 $5K
76536 <1% 119 $5K
82805 <1% 147 $5K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 19 $5K
94726 <1% 216 $5K
97165 <1% 179 $5K
87077 <1% 744 $5K
82607 <1% 396 $4K
76770 <1% 144 $4K
72110 <1% 270 $4K
87641 <1% 230 $4K
85379 <1% 503 $4K
87806 <1% 157 $4K
82550 <1% 761 $4K
73502 <1% 300 $4K
85027 <1% 519 $4K
80349 <1% 305 $4K
83540 <1% 490 $4K
86140 <1% 1,370 $3K
86038 <1% 246 $3K
72131 <1% 58 $3K
85652 <1% 1,336 $3K
84153 <1% 164 $3K
82150 <1% 799 $3K
81025 <1% 1,007 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 25 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 132 $3K
96361 Intravenous infusion, hydration; each additional hour <1% 365 $3K
36415 Collection of venous blood by venipuncture <1% 19,471 $3K
90715 <1% 379 $3K
88342 <1% 113 $3K
97168 <1% 91 $3K
97162 <1% 68 $3K
87430 <1% 416 $3K
Q3014 Telehealth originating site facility fee <1% 188 $2K
74018 <1% 195 $2K
72040 <1% 205 $2K
95806 <1% 38 $2K
X0620 <1% 14 $2K
73080 <1% 217 $2K
93976 <1% 29 $2K
84460 <1% 297 $2K
84450 <1% 293 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 91 $2K
84100 <1% 507 $2K
0071A <1% 47 $2K
83550 <1% 481 $2K
73221 <1% 12 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 132 $2K
87631 <1% 14 $2K
82570 <1% 322 $2K
70496 <1% 16 $2K
94060 <1% 238 $2K
70498 <1% 15 $2K
86850 <1% 337 $2K
73140 <1% 229 $2K
80069 <1% 222 $2K
82746 <1% 176 $2K
94664 <1% 247 $2K
83970 <1% 56 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 779 $2K
62321 <1% 25 $2K
0072A <1% 40 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 43 $2K
73560 <1% 143 $2K
82962 <1% 1,091 $1K
87205 <1% 404 $1K
73100 <1% 129 $1K
81003 <1% 455 $1K
83001 <1% 75 $1K
86900 <1% 406 $1K
84550 <1% 244 $1K
86592 <1% 326 $1K
96523 <1% 91 $1K
80320 <1% 142 $1K
80324 <1% 79 $1K
82043 <1% 152 $1K
72070 <1% 86 $1K
82565 <1% 179 $1K
86901 <1% 406 $1K
82950 <1% 176 $1K
93226 <1% 42 $1K
80076 <1% 123 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 77 $1K
73562 <1% 91 $1K
84156 <1% 304 $1K
17110 <1% 24 $1K
71271 <1% 12 $1K
86430 <1% 147 $1K
73590 <1% 80 $990.66
96376 <1% 320 $985.48
86200 <1% 74 $965.00
80329 <1% 87 $957.51
87522 Neg quan hep c or qual rna <1% 25 $915.21
83615 <1% 198 $909.52
93970 <1% 12 $877.34
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 544 $843.33
20553 <1% 52 $832.55
96415 <1% 41 $808.86
82784 <1% 42 $778.43
72050 <1% 36 $771.75
82375 <1% 163 $768.04
70486 <1% 14 $763.69
86617 <1% 19 $753.28
J7030 Infusion, normal saline solution , 1000 cc <1% 5,687 $711.81
86235 <1% 12 $680.37
80074 <1% 12 $679.35
77080 <1% 13 $628.47
J2704 Injection, propofol, 10 mg <1% 1,573 $627.43
J3490 Unclassified drugs <1% 930 $608.48
76857 <1% 50 $585.20
76801 <1% 13 $498.85
93225 <1% 42 $495.52
73090 <1% 48 $477.71
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 193 $465.48
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 26 $456.58
92587 <1% 16 $442.20
82378 <1% 51 $436.74
82140 <1% 96 $392.50
86160 <1% 13 $365.26
83050 <1% 148 $359.25
87340 <1% 24 $339.00
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,527 $338.95
80179 <1% 444 $338.22
82077 <1% 582 $335.28
69210 <1% 28 $328.00
36600 <1% 43 $327.60
80143 <1% 450 $326.34
84403 <1% 13 $324.00
99406 <1% 238 $321.27
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,279 $293.64
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 165 $290.00
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 294 $274.23
11102 <1% 15 $273.72
12001 <1% 12 $269.50
87581 <1% 851 $249.54
J2785 Injection, regadenoson, 0.1 mg <1% 47 $237.24
C9290 Injection, bupivacaine liposome, 1 mg <1% 56 $227.70
80164 <1% 14 $226.49
72170 <1% 35 $197.09
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 13 $189.40
36591 <1% 227 $188.32
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 70 $178.00
J2270 Injection, morphine sulfate, up to 10 mg <1% 649 $176.82
85007 <1% 39 $166.26
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,414 $156.23
J3370 Injection, vancomycin hcl, 500 mg <1% 222 $152.34
83655 <1% 14 $152.00
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,180 $139.41
85520 <1% 30 $133.82
J1170 Injection, hydromorphone, up to 4 mg <1% 369 $130.80
84436 <1% 12 $124.45
E0113 Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip <1% 15 $119.00
J0690 Injection, cefazolin sodium, 500 mg <1% 464 $116.42
51701 <1% 12 $112.00
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,206 $107.50
82947 <1% 26 $104.40
86376 <1% 12 $94.12
82310 <1% 12 $93.84
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 293 $92.20
82248 <1% 12 $89.37
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 180 $87.04
92555 <1% 13 $86.35
88304 <1% 28 $76.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 317 $74.93
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 163 $74.56
36000 <1% 12 $70.71
J7050 Infusion, normal saline solution, 250 cc <1% 1,046 $69.56
A4311 Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) <1% 56 $55.48
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 596 $55.13
J0780 Injection, prochlorperazine, up to 10 mg <1% 86 $44.02
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 288 $40.92
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 74 $39.43
A9585 Injection, gadobutrol, 0.1 ml <1% 13 $35.00
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 26 $31.50
A4570 Splint <1% 69 $28.62
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 664 $28.35
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 323 $27.69
J2550 Injection, promethazine hcl, up to 50 mg <1% 144 $26.81
3052F <1% 33 $24.57
3051F <1% 131 $20.00
J2060 Injection, lorazepam, 2 mg <1% 121 $19.98
J7060 5% dextrose/water (500 ml = 1 unit) <1% 183 $19.86
J3475 Injection, magnesium sulfate, per 500 mg <1% 92 $16.55
J1650 Injection, enoxaparin sodium, 10 mg <1% 361 $9.16
81050 <1% 12 $8.10
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 37 $7.73
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 30 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 46 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 113 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 46 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 68 $0.00
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 0% 47 $0.00
92579 0% 12 $0.00
3044F 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSUNTAY, RENATO (CFO)
Same official

Other billing entities under SUNTAY, RENATO

Full network →
ProviderLocationPaid
Meadville Medical CenterMeadville, PA$36K
Meadville Medical CenterMeadville, PA$14K
Meadville Medical CenterMeadville, PA$9K
Meadville Physician ServicesMeadville, PA$9K
Meadville Medical CenterMeadville, PA$2K
Meadville Medical CenterMeadville, PA$1K
Meadville Medical CenterMeadville, PA$1K
Meadville Medical CenterMeadville, PA$954.75
Meadville Medical CenterMeadville, PA$581.52
Meadville Medical CenterMeadville, PA$486.50
Meadville Medical CenterMeadville, PA$462.51
Meadville Medical CenterMeadville, PA$47.97

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.